Gemcitabine exhibits a suppressive effect on pancreatic cancer cell growth by regulating processing of PVT1 to miR1207

Gemcitabine serves as a first‐line chemotherapy agent for advanced pancreatic cancer (PC). However, the molecular basis by which gemcitabine exerts its effects is not well‐established, and the targeted genetic pathways remain unclear. Pvt1 oncogene (non‐protein coding) (PVT1) has been reported to be...

Descripción completa

Detalles Bibliográficos
Autores principales: You, Lei, Wang, Huanyu, Yang, Gang, Zhao, Fangyu, Zhang, Jingcheng, Liu, Ziwen, Zhang, Taiping, Liang, Zhiyong, Liu, Changzheng, Zhao, Yupei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6275279/
https://www.ncbi.nlm.nih.gov/pubmed/30341811
http://dx.doi.org/10.1002/1878-0261.12393

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6275279/
https://www.ncbi.nlm.nih.gov/pubmed/30341811
http://dx.doi.org/10.1002/1878-0261.12393

Ejemplares similares